Skip to main navigation Skip to search Skip to main content

An Update on BRAF Inhibitors and Other New Molecular Targets for the Treatment of Malignant Melanoma of the Skin

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalPharmaceutical Science and Research
StatePublished - Jan 1 2013

Keywords

  • Melanoma
  • BRAF inhibitor
  • molecular target
  • vemurafenib

Disciplines

  • Medical Specialties
  • Medicine and Health Sciences
  • Oncology
  • Pharmaceutics and Drug Design
  • Pharmacy and Pharmaceutical Sciences

Cite this